Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835224 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of L-NAME and Midodrine to Increase MAP
A Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT00835224 is a Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 34 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00835224, a Phase 2 study of Spinal Cord Injury and Orthostatic Hypotension, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
After a spinal cord injury the brain is no longer completely in control of the body below the level of injury. This affects many organs and systems in the body, we are interested in understanding how a spinal cord injury affects blood pressure and blood flow to the brain. We are going to study blood pressure while the person is seated in a wheelchair before and after we give the subject medications which should increase blood pressure in a laboratory setting and over the course of a normal day in persons with spinal cord injury.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Midodrine
- DRUG L-NAME
Study Locations (1)
New York
- VA Medical Center, Bronx - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00835224
The ClinicalTrials.gov registry entry for NCT00835224 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (60% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00835224 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00835224 about?
NCT00835224 is a clinical study titled "Safety and Efficacy of L-NAME and Midodrine to Increase MAP". After a spinal cord injury the brain is no longer completely in control of the body below the level of injury. This affects many organs and systems in the body, we are interested in understanding how a spinal cord injury affects blood pressure and blood flow to the brain. We are going to study blood...
What is the current status of trial NCT00835224?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2010-05. Estimated completion is 2013-08.
What conditions does trial NCT00835224 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Orthostatic Hypotension.
What interventions are being tested in trial NCT00835224?
The interventions under investigation include: Placebo (DRUG), Midodrine (DRUG), L-NAME (DRUG).
Who is sponsoring clinical trial NCT00835224?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835224 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
RECRUITING · Phase 2
-
Electrical Control of Bladder in Spinal Cord Injury Patients
COMPLETED · Phase 2
-
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
COMPLETED · Phase 2
-
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.